Cinolazepam
Discover related
2 sources
Mechanism of action
Cinolazepam binds to central benzodiazepine receptors which interact allosterically with GABA receptors. This potentiates the effects of the inhibitory neurotransmitter GABA, increasing the inhibition of the ascending reticular activating system and blocking the cortical and limbic arousal that occurs following stimulation of the reticular pathways.
Pharmacodynamics
Cinolazepam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant activity. It is not approved in Canada or America.
Pharmacokinetics
Half-life
9 hours
Absorption
Bioavailability following oral administration is 90-100%.
Metabolism
Hepatic.
Hepatic.
Half Life: 9 hours
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.